
    
      60 cases of beta-thalassemia/Hb E patients. All patients will be diagnosed with hemoglobin
      typing of beta-thalassemia/Hb E disease and not receive blood transfusion or any treatment at
      least 3 months prior study. The study will be randomized controlled trial that designed
      before and after treatment with antioxidant cocktail. The antioxidant cocktail consists of
      vitamin E 400 IU/day, curcuminoids 500 mg/day, N-acetylcysteine 200 mg/day and deferiprone 50
      mg/kg/day. All patients will receive antioxidant cocktail daily for 12 months. The patients
      will be regularly followed up and analyzed biochemical parameters every two months during
      treatment and after withdrawal for 3 months.
    
  